198 related articles for article (PubMed ID: 9237283)
1. Lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease.
Kim SB; Yang WS; Kang ES; Min WK; Park JS
Perit Dial Int; 1997; 17(3):236-42. PubMed ID: 9237283
[TBL] [Abstract][Full Text] [Related]
2. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
Kimak E; Solski J
Ren Fail; 2002 Mar; 24(2):187-95. PubMed ID: 12071592
[TBL] [Abstract][Full Text] [Related]
3. Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis.
Siamopoulos KC; Elisaf MS; Bairaktari HT; Pappas MB; Sferopoulos GD; Nikolakakis NG
Perit Dial Int; 1995; 15(8):342-7. PubMed ID: 8785232
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
[TBL] [Abstract][Full Text] [Related]
5. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.
Milionis HJ; Elisaf MS; Tselepis A; Bairaktari E; Karabina SA; Siamopoulos KC
Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198
[TBL] [Abstract][Full Text] [Related]
7. The uremic dyslipidemia: a cross-sectional and longitudinal study.
Avram MM; Goldwasser P; Burrell DE; Antignani A; Fein PA; Mittman N
Am J Kidney Dis; 1992 Oct; 20(4):324-35. PubMed ID: 1415199
[TBL] [Abstract][Full Text] [Related]
8. Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis.
Kronenberg F; König P; Neyer U; Auinger M; Pribasnig A; Lang U; Reitinger J; Pinter G; Utermann G; Dieplinger H
J Am Soc Nephrol; 1995 Jul; 6(1):110-20. PubMed ID: 7579063
[TBL] [Abstract][Full Text] [Related]
9. Effect of increasing serum albumin on serum lipoprotein(a) concentration in patients receiving CAPD.
Yang WS; Min WK; Park JS; Kim SB
Am J Kidney Dis; 1997 Oct; 30(4):507-13. PubMed ID: 9328365
[TBL] [Abstract][Full Text] [Related]
10. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
11. Concentration of Lp(a) and other apolipoproteins in predialysis, hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
Kimak E; Solski J; Janicka L; Ksaziek A; Janicki K
Clin Chem Lab Med; 2000 May; 38(5):421-5. PubMed ID: 10952225
[TBL] [Abstract][Full Text] [Related]
12. Residual renal function affects lipid profile in patients undergoing continuous ambulatory peritoneal dialysis.
Kagan A; Elimalech E; Lemer Z; Fink A; Bar-Khayim Y
Perit Dial Int; 1997; 17(3):243-9. PubMed ID: 9237284
[TBL] [Abstract][Full Text] [Related]
13. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.
Misra M; Webb AT; Reaveley DA; Doherty E; O'Donnell M; Seed M; Brown EA
Adv Perit Dial; 1997; 13():168-73. PubMed ID: 9360675
[TBL] [Abstract][Full Text] [Related]
14. Influence of variation at the apolipoprotein E locus on lipid and lipoprotein levels in CAPD patients.
Eggertsen G; Heimbürger O; Stenvinkel P; Berglund L
Nephrol Dial Transplant; 1997 Jan; 12(1):141-4. PubMed ID: 9027789
[TBL] [Abstract][Full Text] [Related]
15. Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients.
Wanner C; Bartens W; Walz G; Nauck M; Schollmeyer P
Nephrol Dial Transplant; 1995; 10(1):75-81. PubMed ID: 7724034
[TBL] [Abstract][Full Text] [Related]
16. Roles of hypoalbuminemia and lipoprotein lipase on hyperlipoproteinemia in continuous ambulatory peritoneal dialysis.
Shoji T; Nishizawa Y; Nishitani H; Yamakawa M; Morii H
Metabolism; 1991 Oct; 40(10):1002-8. PubMed ID: 1943724
[TBL] [Abstract][Full Text] [Related]
17. Elevated lipoprotein(a) and fibrinogen levels [corrected] increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patients.
Bartens W; Nauck M; Schollmeyer P; Wanner C
Perit Dial Int; 1996; 16(1):27-33. PubMed ID: 8616169
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Lp(a) concentrations and some potential effects in hemodialysis, CAPD, transplantation, and control groups, and review of the literature.
Gault MH; Longerich LL; Purchase L; Harnett J; Breckenridge C
Nephron; 1995; 70(2):155-70. PubMed ID: 7566298
[TBL] [Abstract][Full Text] [Related]
19. Identification of apo(a) phenotypes in a Korean population using a standardized nomenclature system based on the number of kringle IV repeats.
Min WK; Lee JO; Kim CH; Song J; Kim JQ
Ann Clin Biochem; 1997 Nov; 34 ( Pt 6)():681-7. PubMed ID: 9367008
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis.
Saltissi D; Morgan C; Rigby RJ; Westhuyzen J
Am J Kidney Dis; 2002 Feb; 39(2):283-90. PubMed ID: 11840368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]